FREEMAN KEVIN D
SEC insider (Form 3/4/5 filer). CIK 0001522478. Director at GALECTIN THERAPEUTICS INC (GALT). 8 reported Form 4/5 transactions since Sep 2024; latest on Jan 16, 2026. Located in NORCROSS, GA.
Companies FREEMAN KEVIN D has filed insider reports for
- GALECTIN THERAPEUTICS INC (GALT): Director
FREEMAN KEVIN D
CIK: 0001522478
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GALECTIN THERAPEUTICS INC
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jan 16, 2026GALT
GALECTIN THERAPEUTICS INC
AwardDirectStock option (right to buy)
60K shares- - Dec 23, 2025GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect5.5K shares at avg. $3.55$20K - Jul 17, 2025GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect5K shares at avg. $2.90$14K - Jan 23, 2025GALT
GALECTIN THERAPEUTICS INC
AwardDirectStock Option (right to buy)
60K shares- - Dec 24, 2024GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect10K shares at avg. $0.81$8K - Oct 17, 2024GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect1.3K shares at avg. $2.64$3K - Oct 16, 2024GALT
GALECTIN THERAPEUTICS INC
PurchaseDirect5K shares at avg. $2.70$14K - Oct 16, 2024GALT
GALECTIN THERAPEUTICS INC
PurchaseIndirect5K shares at avg. $2.70$14K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 16, 2026 | GALT GALECTIN THERAPEUTICS INC | Award Stock option (right to buy) | 60,000 | - | - | Direct |
| Dec 23, 2025 | GALT GALECTIN THERAPEUTICS INC | Purchase | 5,500 | $3.55 | $19,514 | Direct |
| Jul 17, 2025 | GALT GALECTIN THERAPEUTICS INC | Purchase | 5,000 | $2.90 | $14,495 | Direct |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | Award Stock Option (right to buy) | 60,000 | - | - | Direct |
| Dec 24, 2024 | GALT GALECTIN THERAPEUTICS INC | Purchase | 10,000 | $0.81 | $8,134 | Direct |
| Oct 17, 2024 | GALT GALECTIN THERAPEUTICS INC | Purchase | 1,300 | $2.64 | $3,432 | Direct |
| Oct 16, 2024 | GALT GALECTIN THERAPEUTICS INC | Purchase | 5,000 | $2.70 | $13,500 | Direct |
| Oct 16, 2024 | GALT GALECTIN THERAPEUTICS INC | Purchase | 5,000 | $2.70 | $13,500 | Indirect |
1-8 of 8 transactions